
---
title: '新冠药概念股走强 博腾股份等20%涨停'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6585'
author: 证券时报网
comments: false
date: Mon, 14 Feb 2022 09:40:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6585'
---

<div>   
<p>证券时报e公司讯，新冠药概念股走强，截至发稿，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ301201" style="color: #2f67d1;text-decoration: none;" code="301201" target="_blank">诚达药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300363" style="color: #2f67d1;text-decoration: none;" code="300363" target="_blank">博腾股份</a>20%涨停，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300261" style="color: #2f67d1;text-decoration: none;" code="300261" target="_blank">雅本化学</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ301089" style="color: #2f67d1;text-decoration: none;" code="301089" target="_blank">拓新药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600668" style="color: #2f67d1;text-decoration: none;" code="600668" target="_blank">尖峰集团</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002349" style="color: #2f67d1;text-decoration: none;" code="002349" target="_blank">精华制药</a>等均大涨。消息面上，国家药监局应急附条件批准辉瑞公司新冠病毒治疗药物奈玛特韦片/利托那韦片组合包装进口注册。</p>

                  
</div>
            